Scientists track Parkinson's patients for future cell therapy
NCT ID NCT05779475
Summary
This study follows 96 people with moderate Parkinson's disease for up to two years to track how their symptoms change over time. Participants continue their regular medications while researchers monitor their movement abilities during both 'on' and 'off' medication periods. The study also aims to identify suitable candidates for future cell therapy transplantation research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Neuroscience
Cambridge, CB2 0PY, United Kingdom
-
Joe C.Wen & Fam CTR for Adv Care
Irvine, California, 92612, United States
-
Keio University Hospital
Shinjuku-ku, Tokyo, 160-8582, Japan
-
NY Presbyt Hosp-W Cornell Med
New York, New York, 10021, United States
-
NYU Langone Health
New York, New York, 10016, United States
-
Neurologimottagningen Lund
Lund, 222 42, Sweden
-
Region Skane Skanes Universitetssjukhus
Lund, 222 42, Sweden
-
University of Cambridge - Clinical Neuroscience
Cambridge, CB2 0PY, United Kingdom
Conditions
Explore the condition pages connected to this study.